Table 2. Structures and in vitro inhibitory potencies of compounds 54–59 against the β5i subunit of human iCP.
| ||
| Compound | R | RA (%) at 10 μM or IC50 for β5i (nM) |
| 54 |
|
62 ± 3 |
| 55 |
|
IC50 = 1830 ± 380 |
| 56 |
|
101 ± 7 |
| 57 |
|
111 ± 16 |
| 58 |
|
99 ± 9 |
| 59 |
|
102 ± 9 |